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Background: Laparoscopic radical nephrectomy (LRN) is the actual gold-standard for the treatment of clinically
localized renal cell carcinoma (RCC) (cT1-2 with no indications for nephron-sparing surgery). Limited evidence is
currently available on the role of robotics in the field of radical nephrectomy. The aim of the current study was to
provide a systematic review of the current evidence on the role of robotic radical nephrectomy (RRN) and to
analyze the comparative studies between RRN and open nephrectomy (ON)/LRN.
Methods: A Medline search was performed between 2000–2013 with the terms “robotic radical nephrectomy”,
“robot-assisted laparoscopic nephrectomy”, “radical nephrectomy”. Six RRN case-series and four comparative studies
between RRN and (ON)/pure or hand-assisted LRN were identified.
Results: Current literature produces a low level of evidence for RRN in the treatment of RCC, with only one
prospective study available. Mean operative time (OT) ranges between 127.8-345 min, mean estimated blood loss
(EBL) ranges between 100–273.6 ml, and mean hospital stay (HS) ranges between 1.2-4.3 days. The comparison
between RRN and LRN showed no differences in the evaluated outcomes except for a longer OT for RRN as
evidenced in two studies. Significantly higher direct costs and costs of the disposable instruments were also
observed for RRN. The comparison between RRN and ON showed that ON is characterized by shorter OT but
higher EBL, higher need of postoperative analgesics and longer HS.
Conclusions: No advantage of robotics over standard laparoscopy for the treatment of clinically localized RCC was
evidenced. Promising preliminary results on oncologic efficacy of RRN have been published on the T3a-b disease.
Fields of wider application of robotics should be researched where indications for open surgery still persist.
Keywords: Robotic nephrectomy, Robotic radical nephrectomy, Robot-assisted laparoscopic radical nephrectomy,
Radical nephrectomy, Renal cell carcinomaBackground
Renal cell carcinoma (RCC) together with renal pelvis
cancer represents the 3.8% of all new cancer cases in the
US, with an estimated 63920 new cases and 13860 cancer–
related deaths in 2014 [1]. Laparoscopic radical nephrec-
tomy (LRN) is the actual gold-standard for the treatment of
clinically localized RCC (cT1-2 with no indications for
nephron-sparing surgery) [2].
The first robotic radical nephrectomy (RRN) for RCC
was described by Klingler et al. [3] in 2000. Before that,* Correspondence: tasospao2003@yahoo.com
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article, unless otherwise stated.only feasibility studies of simple robotic nephrectomy
on the suine model [4], one robotic nephrectomy on hu-
man for a case of a nonfunctioning hydronephrotic kid-
ney -owing to a ureteropelvic junction obstruction- [5]
and 11 robotic live-donor nephrectomies [6,7] were
published, with promising results.
Aim of the current manuscript was to perform a sys-
tematic review of the current evidence on the role of
RRN. The available comparative studies between RRN
and ON/LRN were also analyzed.Methods
We performed a MedLine search for peer-reviewed stud-
ies, published from January 2000- December 2013, onCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ical nephrectomy”, “robot-assisted laparoscopic nephrec-
tomy”, “radical nephrectomy”.
Two individuals independently screened the titles and
abstracts of each citation. The reference lists of the eligible
articles were reviewed and the “Related citations” PubMed
feature was utilized. Comparative studies between RRN
and LRN or ON were also included in this review.
Abstracts and manuscripts reporting <5 cases or refer-
ring on robotics for live-donor nephrectomy, nephroure-
terectomy, partial nephrectomy or on robotic simple
nephrectomy were excluded. Manuscripts in languages
other than English were not considered.
Manuscripts have been assessed according to their
level of scientific evidence (Oxford Center for Evidence-
based Medicine, March 2009) [8].
Results
One hundred and seventy-nine manuscripts were ini-
tially identified. Figure 1 provides a four-phase diagram
on the flow of information through the different phases
of this systematic review. By the application of the exclu-
sion criteria described above, ten manuscripts were ul-
timately eligible for inclusion in this systematic review.
Six studies were classified as case-series with a retrospect-
ive evaluation of the reported data [3,9-13], three studies
were classified as case-comparative series with a retro-
spective evaluation of the reported data [14-16] while one
study was a prospective case–control study [17]. Nine
manuscripts refer on the traditional multi-port robotic ac-
cess [3,9-13,15-17] while one on the single-site approach
(robotic laparoendoscopic single-site surgery (R-LESS))
[14]. The transperitoneal route was mainly adopted. Sev-
eral techniques of hilar control are described, such as
endovascular stapler [3], hemoclips [13], Hemolock clips
[17] or suture ligation/robotic Hemolock clips/staplers [9],
based on the preferences of the operating surgeons.
Tables 1 and 2 refer on the perioperative and onco-
logic data of the published series, respectively. Table 3
reports on the described complications.
Discussion
While the first RRN was described in 2000 [3] only few
studies have been published until now; the utility of the
robotic platform in the field of RN, in fact, has been
questioned mainly due to concerns such as higher costs,
set up time, absence of force feedback and longer global
operative times compared to LRN. Furthermore, in case
of conversion for significant vascular complications, the
initial part of the surgery has to be managed by the bed-
side assistant, before the main surgeon scrubs in [10,11].
Overall, the current literature provides a low level of evi-
dence for RRN in the treatment of RCC. The majority of
the studies are small retrospective case-series with limitedfollow-up; only one case–control study reports a prospect-
ive evaluation of the collected data [17].
The transperitoneal route was the preferable way for
accessing the kidney fossa. However, robotic assistance
may also facilitate the retroperitoneal approach, offering
precise dissection in a confined working space. Rogers
et al. [9] describe the retroperitoneal RRN for three pa-
tients, two with extensive prior abdominal surgery and
one on peritoneal dialysis.
As shown in Table 1, RRN is performed in acceptable
operative times, with low EBL and conversion rates. The
highest number of conversions to ON is reported in the
study of Dogra et al. [10]; the primary reason for conver-
sion was bleeding in all these cases.
RRN also provides acceptable, short-term oncologic effi-
cacy (Table 2), both for the clinically localized and locally
advanced RCC, even in cases of RCC with thrombus of the
inferior vena cava (IVC) [12]. While the published series
present only a short follow-up, no local or distant recur-
rences were observed. Based on these short-term data, no
significant differences in long-term oncologic outcomes
should be expected for RRN when compared to ON or
LRN. However, a recent study [18], reported on the first
case of tumor seeding in the omentum found in a female
patient after previous transperitoneal RRN for papillary,
low grade RCC (T2aN0M0). Two years after the robotic
operation, the patient was diagnosed with cervical clear cell
carcinoma and underwent radical hysterectomy with
lymphadenectomy and omentectomy (with papillary RCC
revealed in the pathological evaluation).
The rate of intra e postoperative complications was also
low (Table 3). No perioperative deaths were reported. Post-
operative pain evaluated by the 0–10 visual analogue scale
(VAS) was generally low [8] (and mainly referred right after
surgery). Use of analgesics was also low and limited to the
day of surgery and the first postoperative day.
In the evaluated series, several potential advantages of
the robotic approach on the pure laparoscopic one in
the field of radical nephrectomy have been suggested:
1) The fourth robotic arm may provide upward retraction
of the kidney, placing the renal hilum on stretch to
facilitate a two-handed, precise dissection of the hilar
vessels. Moreover, the correct use of the fourth robotic
arm reduces the OTand minimizes the complexity of
the laparoscopic tasks being performed by the bedside
assistant to basic maneuvers such as suctioning,
irrigating and changing of robotic instruments; thus,
the console surgeon independence gets maximized.
2) The use of the articulated Hemolock applicator
aids in the control of the kidney vessels under ideal
angles, that sometimes results are reached with
difficulty with a conventional laparoscopic
Hemolock-clip applier.
Table 1 Perioperative outcomes of RRN for RCC
Author Pts BMI OT (min) EBL (ml) Morph. Eq (mg) HS (d) Tumor size Conversion Level of evidence
Klingler [3] 5 28 321 (M) 150 (M) 28 (M) 3 (M) 66 cm3 (M) 1→ HA-LRN IV
Rogers [9] 35 30.5 291 (m) 221 (m) 18.5 (m) 2.5 (m) 5.1 cm (m) None IV
Dogra [10] 23 NR 132.7 (m) 270 (m) NR 3 (m) 6.38 cm (m) 3→ON IV
Rogers [11] 18 NR 224 with 4th arm, 322 without (m) NR NR NR NR NR IV
Abaza [12] 5 36.6 327(m) 170 (m) NR 1.2 (m) 10.4 cm (m) None IV
Nazemi [15] 6 27.6 345 (M) 125 (M) 19 (M) 3 (M) 4.5 cm (M) 1→ HA-LRN IV
Hemal [17] 15 28.3 221 (m) 210 (m) 14.3 (m) 3.5 (m) 6.7 cm (m) 1→ON IIIb
Boger [16] 13 29 168 (M) 100 (m) 30 (m) 2 (m) 4.8 cm (m) 1→ LRN IV
Lorenzo [13] 38 24.3 127.8 (m) 273.6 (m) NR 4.3 (m) NR None IV
White [14] 10 28.7 167.5 (M) 100 (M) 25.3 (M) 2.5 (M) 4.8 cm (M) None IV
Pts = patients, BMI = body mass index, OT = operative time, EBL = estimated blood loss, Morph.Eq =morphine equivalents, HS = hospital stay. Level of evidence
IV = case-series (and poor quality cohort and case–control studies), IIIb = individual case–control study. NR = not reported, HA-LRN = hand-assisted laparoscopic
radical nephrectomy, ON = open nephrectomy. m =mean, M =median.
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Figure 1 Flow of information through the different phases of this systematic review, according to the PRISMA Flow Diagram
(http://www.prisma-statement.org/statement.htm).
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Table 2 Oncologic outcomes of RRN for RCC
Author Mean (m) or median
(M) follow-up (mo)
PSM Local or distant
recurrence
Rogers [9] 15.7 (m) 0 No
Dogra [10] 29.4 (m) 0 No
Nazemi [15] 4 (M) 0 No
Hemal [17] 8.3 (m) NR No
Abaza [12] 15.4 (m) 0 No
Klingler [3] NR 0 NR
Lorenzo [13] 12 (M) 0 No
White [14] 10.5 (m) NR NR
Boger [16] NR NR NR
Rogers [11] NR NR NR
NR = not reported.
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of the kidney vessels, similar to ON.
4) Finally, some authors suggest the use of the robot in
the field of RN as a training platform for more
challenging surgical procedures, such as robotic
partial nephrectomy [9].
However, the aforementioned advantages do not seem
to provide better outcomes for the robotic approach
over the traditional LRN/ON in the field of radical neph-
rectomy. In fact, the comparative studies between RRN
and LRN [15-17] showed no differences in the evaluated
outcomes except for a longer operative time (OT) for
the robotic approach as evidenced in two studies [15,17].
It should be remembered, however, that the published
series on RRN described the very first cases of the sur-
geons and consequently the outcomes may be influenced
by the learning-curve issues.
Significantly higher costs were also observed for RRN:
when the direct costs (i.e. instruments, nursing salaries,Table 3 Complications/conversions of RRN for RCC
(where reported)
Rogers [11] 4 wound dehiscences in morbidly obese patients
Nazemi [15] 1 stapler failure: renal vein bleeding
and conversion in HA-LRN
Hemal [17] 2 vascular complications, 1 wound infection, 2 ileus
Boger [16] 2 pulmonary embolism, 1 pancreas injury,
1 liver laceration
Dogra [10] Hilar bleeding with necessity of transfusion,
1 transfusion, 2 fever, 1 vomiting,
1 wound infection, 1 atrial fibrillation
Lorenzo [13] 7.9% transfusion rate
White [14] Skin infection
Abaza [12] None reported
Klingler [3] 1 bleeding requiring conversion to HA-LRNoperative room and recovery room time) are evaluated, a
total save of about 1300$ is observed for pure laparos-
copy compared to RRN. Disposable instruments cost less
in the pure laparoscopic group (1.573$ vs 1.942$), a dif-
ference that could be even higher if the surgeon spares
the costs of the harmonic scalpel use (about 482 $ in
this study) [16]. In a very recent study comparing costs
between RRN and LRN [19], 24,312 radical nephrec-
tomy cases performed either laparoscopically (68%) or
robotically (32%) were analyzed. There was no demo-
graphic difference between RRN and LRN cases. Me-
dian total charges were $47,036 vs $38,068 for RRN vs
LRN (p <0.001). Median total hospital costs for RRN
were $15,149 compared to $11,735 for LRN (p <0.001).
Compared to the laparoscopic approach robotic assist-
ance conferred an estimated $4,565 and $11,267 in-
crease in hospital costs and charges, respectively, when
adjusted for adapted Charlson comorbidity index score,
perioperative complications and length of stay (p <0.001).
The authors concluded that RRN results in increased
medical expense without improving patient morbidity.
The comparison between RRN and ON showed that
ON is characterized by shorter OT, higher EBL, higher
need of postoperative analgesics and longer hospital stay
(HS) [15].
At the current state of the art and according to the
most recent EAU guidelines on renal robotics [20], in
ablative kidney surgery, robotics will produce no better
outcomes compared to laparoscopy. The use of robotics
in the field of RN for clinically localized RCC seems ra-
ther a technical overtreatment; thus, the use of pure
laparoscopy to perform simple or radical nephrectomy is
recommended (grade of recommendation C).
Anyway, there exist two potential areas of radical neph-
rectomy where the robotic approach may help to over-
come the technical difficulties of the pure laparoscopy:
A) Field of R-LESS: the robotic platform provides the
means to overcome technical constraints of the pure
laparoscopic approach such as lack of triangulation,
clashing of instruments and limited operating space.
The comparison between R-LESS and conventional
laparoscopy shows no difference in median OT, EBL,
VAS and complication rates, while R-LESS may
result in reduced inpatient narcotic requirements
and HS compared to conventional LRN [14]. The
promising results of this study should be interpreted
with caution, because of issues related to the small
number of the enrolled patients, to the retrospective
design, to the short follow-up as well as to the
absence of cases requiring adrenalectomy or
significant hepatic or splenic retraction.
B) Field of RCC with associated IVC thrombi:
Currently these cases are mainly performed through
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series on the use of pure laparoscopy have been
published in this context, but in their majority the
laparoscopic approach is used for the nephrectomy
while the surgical time of thrombectomy is
performed through an open incision [21,22] or with
hand-assistance [23]. Some cases of pure or
HA-laparoscopy for the entire procedure
(i.e. nephrectomy and thrombectomy) have been
described, limited to short thrombi [24,25].
In 2011 Abaza published the first series of five right
radical nephrectomies plus thrombectomy for kidney
tumors with IVC thrombus of various levels performed
robotically [12]. “Simple” cases of short IVC thrombi
as well as more “complex” cases requiring cross-
clamping of the IVC and of the left renal vein were de-
scribed. The results of the procedure were impressive,
with a mean OT of 321 min and mean EBL of 170 ml
for a mean tumor size of 10.4 cm. No transfusions and
no complications were observed, while mean HS was
only 1.2 days. The author, however, suggested that the
procedure is challenging since serious and potentially
fatal complications can occur. Extensive experience
with robotic renal surgery and strong background in
open urologic vascular surgery is suggested, while it
should be recorded that the robotic surgeon is away
from the bedside during such a critical procedure. To
minimize the risk of tumor embolism, the renal artery
should be preliminarily controlled preferably at the
interaortocaval space in order to minimize the manipu-
lation of the IVC. All the lumbar veins confluent to that
segment of IVC should be clipped in order to guarantee
a bloodless field. In cases of a short IVC thrombus, the
fourth robotic arm may provide a lateral kidney retrac-
tion in order to pull the thrombus in the renal vein and
allows for a subsequent application of a vascular stapler
at the emergence of the renal vein, avoiding opening of
the IVC.
Another case of RRN for a large renal mass with vena
cava thrombus (cT3b), requiring a complete cross-
clamping of the vena cava and entirely performed intra-
corporeally by relatively novice robotic surgeons was
recently described [26].
Finally, it was recently demonstrated that robotic tech-
nology is associated with increased use of partial neph-
rectomy [27]; recent studies also document oncologic
equivalence between partial and radical nephrectomies
even for masses >7 cm [28,29]. Combining these data,
an indirect increase in the number of RRN should be ex-
pected because of intraoperative conversions of proce-
dures started with intent of nephron-sparing surgery
(due to complications, technical difficulties or prolonged
warm ischemia times), at least in the near future.Conclusions
Robotic nephrectomy is a feasible, safe and oncologically
effective surgical treatment for clinically localized RCC.
However, current literature does not provide any advan-
tage for RRN if compared to standard laparoscopy; thus,
RRN seems rather a “technical overtreatment”. Further
future applications of robotics -in the field of radical
nephrectomy- should be investigated where indications
for open surgery still persist like the presence of an asso-
ciated IVC thrombus.
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